Global Infectious Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
According to our (Global Info Research) latest study, the global Infectious Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
This report is a detailed and comprehensive analysis for global Infectious Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Infectious Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Infectious Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Infectious Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Infectious Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Limited (Australia), Bavarian Nordic (Denmark), GlaxoSmithKline plc. (U.K.), Emergent Bio Solutions Inc. (U.S.) and MedImmune LLC (U.S.), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Infectious Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Infectious Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Infectious Vaccines, with price, sales, revenue and global market share of Infectious Vaccines from 2018 to 2023.
Chapter 3, the Infectious Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infectious Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Infectious Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Infectious Vaccines.
Chapter 14 and 15, to describe Infectious Vaccines sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Infectious Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
This report is a detailed and comprehensive analysis for global Infectious Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Infectious Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Infectious Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Infectious Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Infectious Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Limited (Australia), Bavarian Nordic (Denmark), GlaxoSmithKline plc. (U.K.), Emergent Bio Solutions Inc. (U.S.) and MedImmune LLC (U.S.), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Infectious Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Preventive Vaccine
- Therapeutic Vaccine
- Adults
- Pediatrics
- CSL Limited (Australia)
- Bavarian Nordic (Denmark)
- GlaxoSmithKline plc. (U.K.)
- Emergent Bio Solutions Inc. (U.S.)
- MedImmune LLC (U.S.)
- Johnson and Johnson (U.S.)
- Novartis AG (Switzerland)
- Merck and Company (U.S.)
- Sanofi Pasteur (France)
- Pfizer Inc. (U.S.)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Infectious Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Infectious Vaccines, with price, sales, revenue and global market share of Infectious Vaccines from 2018 to 2023.
Chapter 3, the Infectious Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infectious Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Infectious Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Infectious Vaccines.
Chapter 14 and 15, to describe Infectious Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Infectious Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Infectious Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Preventive Vaccine
1.3.3 Therapeutic Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Infectious Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Pediatrics
1.5 Global Infectious Vaccines Market Size & Forecast
1.5.1 Global Infectious Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Infectious Vaccines Sales Quantity (2018-2029)
1.5.3 Global Infectious Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 CSL Limited (Australia)
2.1.1 CSL Limited (Australia) Details
2.1.2 CSL Limited (Australia) Major Business
2.1.3 CSL Limited (Australia) Infectious Vaccines Product and Services
2.1.4 CSL Limited (Australia) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Limited (Australia) Recent Developments/Updates
2.2 Bavarian Nordic (Denmark)
2.2.1 Bavarian Nordic (Denmark) Details
2.2.2 Bavarian Nordic (Denmark) Major Business
2.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Product and Services
2.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bavarian Nordic (Denmark) Recent Developments/Updates
2.3 GlaxoSmithKline plc. (U.K.)
2.3.1 GlaxoSmithKline plc. (U.K.) Details
2.3.2 GlaxoSmithKline plc. (U.K.) Major Business
2.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product and Services
2.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline plc. (U.K.) Recent Developments/Updates
2.4 Emergent Bio Solutions Inc. (U.S.)
2.4.1 Emergent Bio Solutions Inc. (U.S.) Details
2.4.2 Emergent Bio Solutions Inc. (U.S.) Major Business
2.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product and Services
2.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Developments/Updates
2.5 MedImmune LLC (U.S.)
2.5.1 MedImmune LLC (U.S.) Details
2.5.2 MedImmune LLC (U.S.) Major Business
2.5.3 MedImmune LLC (U.S.) Infectious Vaccines Product and Services
2.5.4 MedImmune LLC (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MedImmune LLC (U.S.) Recent Developments/Updates
2.6 Johnson and Johnson (U.S.)
2.6.1 Johnson and Johnson (U.S.) Details
2.6.2 Johnson and Johnson (U.S.) Major Business
2.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Product and Services
2.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Johnson and Johnson (U.S.) Recent Developments/Updates
2.7 Novartis AG (Switzerland)
2.7.1 Novartis AG (Switzerland) Details
2.7.2 Novartis AG (Switzerland) Major Business
2.7.3 Novartis AG (Switzerland) Infectious Vaccines Product and Services
2.7.4 Novartis AG (Switzerland) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis AG (Switzerland) Recent Developments/Updates
2.8 Merck and Company (U.S.)
2.8.1 Merck and Company (U.S.) Details
2.8.2 Merck and Company (U.S.) Major Business
2.8.3 Merck and Company (U.S.) Infectious Vaccines Product and Services
2.8.4 Merck and Company (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck and Company (U.S.) Recent Developments/Updates
2.9 Sanofi Pasteur (France)
2.9.1 Sanofi Pasteur (France) Details
2.9.2 Sanofi Pasteur (France) Major Business
2.9.3 Sanofi Pasteur (France) Infectious Vaccines Product and Services
2.9.4 Sanofi Pasteur (France) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Pasteur (France) Recent Developments/Updates
2.10 Pfizer Inc. (U.S.)
2.10.1 Pfizer Inc. (U.S.) Details
2.10.2 Pfizer Inc. (U.S.) Major Business
2.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Product and Services
2.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Inc. (U.S.) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFECTIOUS VACCINES BY MANUFACTURER
3.1 Global Infectious Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Infectious Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Infectious Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Infectious Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Infectious Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Infectious Vaccines Manufacturer Market Share in 2022
3.5 Infectious Vaccines Market: Overall Company Footprint Analysis
3.5.1 Infectious Vaccines Market: Region Footprint
3.5.2 Infectious Vaccines Market: Company Product Type Footprint
3.5.3 Infectious Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Infectious Vaccines Market Size by Region
4.1.1 Global Infectious Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Infectious Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Infectious Vaccines Average Price by Region (2018-2029)
4.2 North America Infectious Vaccines Consumption Value (2018-2029)
4.3 Europe Infectious Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Infectious Vaccines Consumption Value (2018-2029)
4.5 South America Infectious Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Infectious Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Infectious Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Infectious Vaccines Consumption Value by Type (2018-2029)
5.3 Global Infectious Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Infectious Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Infectious Vaccines Consumption Value by Application (2018-2029)
6.3 Global Infectious Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Infectious Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Infectious Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Infectious Vaccines Market Size by Country
7.3.1 North America Infectious Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Infectious Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Infectious Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Infectious Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Infectious Vaccines Market Size by Country
8.3.1 Europe Infectious Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Infectious Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Infectious Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Infectious Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Infectious Vaccines Market Size by Region
9.3.1 Asia-Pacific Infectious Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Infectious Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Infectious Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Infectious Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Infectious Vaccines Market Size by Country
10.3.1 South America Infectious Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Infectious Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Infectious Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Infectious Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Infectious Vaccines Market Size by Country
11.3.1 Middle East & Africa Infectious Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Infectious Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Infectious Vaccines Market Drivers
12.2 Infectious Vaccines Market Restraints
12.3 Infectious Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Infectious Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Infectious Vaccines
13.3 Infectious Vaccines Production Process
13.4 Infectious Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Infectious Vaccines Typical Distributors
14.3 Infectious Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Infectious Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Infectious Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Preventive Vaccine
1.3.3 Therapeutic Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Infectious Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Pediatrics
1.5 Global Infectious Vaccines Market Size & Forecast
1.5.1 Global Infectious Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Infectious Vaccines Sales Quantity (2018-2029)
1.5.3 Global Infectious Vaccines Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 CSL Limited (Australia)
2.1.1 CSL Limited (Australia) Details
2.1.2 CSL Limited (Australia) Major Business
2.1.3 CSL Limited (Australia) Infectious Vaccines Product and Services
2.1.4 CSL Limited (Australia) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CSL Limited (Australia) Recent Developments/Updates
2.2 Bavarian Nordic (Denmark)
2.2.1 Bavarian Nordic (Denmark) Details
2.2.2 Bavarian Nordic (Denmark) Major Business
2.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Product and Services
2.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bavarian Nordic (Denmark) Recent Developments/Updates
2.3 GlaxoSmithKline plc. (U.K.)
2.3.1 GlaxoSmithKline plc. (U.K.) Details
2.3.2 GlaxoSmithKline plc. (U.K.) Major Business
2.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product and Services
2.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline plc. (U.K.) Recent Developments/Updates
2.4 Emergent Bio Solutions Inc. (U.S.)
2.4.1 Emergent Bio Solutions Inc. (U.S.) Details
2.4.2 Emergent Bio Solutions Inc. (U.S.) Major Business
2.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product and Services
2.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Developments/Updates
2.5 MedImmune LLC (U.S.)
2.5.1 MedImmune LLC (U.S.) Details
2.5.2 MedImmune LLC (U.S.) Major Business
2.5.3 MedImmune LLC (U.S.) Infectious Vaccines Product and Services
2.5.4 MedImmune LLC (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MedImmune LLC (U.S.) Recent Developments/Updates
2.6 Johnson and Johnson (U.S.)
2.6.1 Johnson and Johnson (U.S.) Details
2.6.2 Johnson and Johnson (U.S.) Major Business
2.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Product and Services
2.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Johnson and Johnson (U.S.) Recent Developments/Updates
2.7 Novartis AG (Switzerland)
2.7.1 Novartis AG (Switzerland) Details
2.7.2 Novartis AG (Switzerland) Major Business
2.7.3 Novartis AG (Switzerland) Infectious Vaccines Product and Services
2.7.4 Novartis AG (Switzerland) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis AG (Switzerland) Recent Developments/Updates
2.8 Merck and Company (U.S.)
2.8.1 Merck and Company (U.S.) Details
2.8.2 Merck and Company (U.S.) Major Business
2.8.3 Merck and Company (U.S.) Infectious Vaccines Product and Services
2.8.4 Merck and Company (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck and Company (U.S.) Recent Developments/Updates
2.9 Sanofi Pasteur (France)
2.9.1 Sanofi Pasteur (France) Details
2.9.2 Sanofi Pasteur (France) Major Business
2.9.3 Sanofi Pasteur (France) Infectious Vaccines Product and Services
2.9.4 Sanofi Pasteur (France) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Pasteur (France) Recent Developments/Updates
2.10 Pfizer Inc. (U.S.)
2.10.1 Pfizer Inc. (U.S.) Details
2.10.2 Pfizer Inc. (U.S.) Major Business
2.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Product and Services
2.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Inc. (U.S.) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFECTIOUS VACCINES BY MANUFACTURER
3.1 Global Infectious Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Infectious Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Infectious Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Infectious Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Infectious Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Infectious Vaccines Manufacturer Market Share in 2022
3.5 Infectious Vaccines Market: Overall Company Footprint Analysis
3.5.1 Infectious Vaccines Market: Region Footprint
3.5.2 Infectious Vaccines Market: Company Product Type Footprint
3.5.3 Infectious Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Infectious Vaccines Market Size by Region
4.1.1 Global Infectious Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Infectious Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Infectious Vaccines Average Price by Region (2018-2029)
4.2 North America Infectious Vaccines Consumption Value (2018-2029)
4.3 Europe Infectious Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Infectious Vaccines Consumption Value (2018-2029)
4.5 South America Infectious Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Infectious Vaccines Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Infectious Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Infectious Vaccines Consumption Value by Type (2018-2029)
5.3 Global Infectious Vaccines Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Infectious Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Infectious Vaccines Consumption Value by Application (2018-2029)
6.3 Global Infectious Vaccines Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Infectious Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Infectious Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Infectious Vaccines Market Size by Country
7.3.1 North America Infectious Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Infectious Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Infectious Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Infectious Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Infectious Vaccines Market Size by Country
8.3.1 Europe Infectious Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Infectious Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Infectious Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Infectious Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Infectious Vaccines Market Size by Region
9.3.1 Asia-Pacific Infectious Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Infectious Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Infectious Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Infectious Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Infectious Vaccines Market Size by Country
10.3.1 South America Infectious Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Infectious Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Infectious Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Infectious Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Infectious Vaccines Market Size by Country
11.3.1 Middle East & Africa Infectious Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Infectious Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Infectious Vaccines Market Drivers
12.2 Infectious Vaccines Market Restraints
12.3 Infectious Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Infectious Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Infectious Vaccines
13.3 Infectious Vaccines Production Process
13.4 Infectious Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Infectious Vaccines Typical Distributors
14.3 Infectious Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Infectious Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Infectious Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Limited (Australia) Basic Information, Manufacturing Base and Competitors
Table 4. CSL Limited (Australia) Major Business
Table 5. CSL Limited (Australia) Infectious Vaccines Product and Services
Table 6. CSL Limited (Australia) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Limited (Australia) Recent Developments/Updates
Table 8. Bavarian Nordic (Denmark) Basic Information, Manufacturing Base and Competitors
Table 9. Bavarian Nordic (Denmark) Major Business
Table 10. Bavarian Nordic (Denmark) Infectious Vaccines Product and Services
Table 11. Bavarian Nordic (Denmark) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bavarian Nordic (Denmark) Recent Developments/Updates
Table 13. GlaxoSmithKline plc. (U.K.) Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline plc. (U.K.) Major Business
Table 15. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product and Services
Table 16. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline plc. (U.K.) Recent Developments/Updates
Table 18. Emergent Bio Solutions Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 19. Emergent Bio Solutions Inc. (U.S.) Major Business
Table 20. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product and Services
Table 21. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Emergent Bio Solutions Inc. (U.S.) Recent Developments/Updates
Table 23. MedImmune LLC (U.S.) Basic Information, Manufacturing Base and Competitors
Table 24. MedImmune LLC (U.S.) Major Business
Table 25. MedImmune LLC (U.S.) Infectious Vaccines Product and Services
Table 26. MedImmune LLC (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MedImmune LLC (U.S.) Recent Developments/Updates
Table 28. Johnson and Johnson (U.S.) Basic Information, Manufacturing Base and Competitors
Table 29. Johnson and Johnson (U.S.) Major Business
Table 30. Johnson and Johnson (U.S.) Infectious Vaccines Product and Services
Table 31. Johnson and Johnson (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Johnson and Johnson (U.S.) Recent Developments/Updates
Table 33. Novartis AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 34. Novartis AG (Switzerland) Major Business
Table 35. Novartis AG (Switzerland) Infectious Vaccines Product and Services
Table 36. Novartis AG (Switzerland) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novartis AG (Switzerland) Recent Developments/Updates
Table 38. Merck and Company (U.S.) Basic Information, Manufacturing Base and Competitors
Table 39. Merck and Company (U.S.) Major Business
Table 40. Merck and Company (U.S.) Infectious Vaccines Product and Services
Table 41. Merck and Company (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Merck and Company (U.S.) Recent Developments/Updates
Table 43. Sanofi Pasteur (France) Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Pasteur (France) Major Business
Table 45. Sanofi Pasteur (France) Infectious Vaccines Product and Services
Table 46. Sanofi Pasteur (France) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sanofi Pasteur (France) Recent Developments/Updates
Table 48. Pfizer Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 49. Pfizer Inc. (U.S.) Major Business
Table 50. Pfizer Inc. (U.S.) Infectious Vaccines Product and Services
Table 51. Pfizer Inc. (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Pfizer Inc. (U.S.) Recent Developments/Updates
Table 53. Global Infectious Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Infectious Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Infectious Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Infectious Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Infectious Vaccines Production Site of Key Manufacturer
Table 58. Infectious Vaccines Market: Company Product Type Footprint
Table 59. Infectious Vaccines Market: Company Product Application Footprint
Table 60. Infectious Vaccines New Market Entrants and Barriers to Market Entry
Table 61. Infectious Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Infectious Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Infectious Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Infectious Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Infectious Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Infectious Vaccines Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Infectious Vaccines Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Infectious Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Infectious Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Infectious Vaccines Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Infectious Vaccines Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Infectious Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Infectious Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Infectious Vaccines Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Infectious Vaccines Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Infectious Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Infectious Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Infectious Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Infectious Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Infectious Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Infectious Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Infectious Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Infectious Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Infectious Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Infectious Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Infectious Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Infectious Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Infectious Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Infectious Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Infectious Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Infectious Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Infectious Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Infectious Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Infectious Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Infectious Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Infectious Vaccines Raw Material
Table 121. Key Manufacturers of Infectious Vaccines Raw Materials
Table 122. Infectious Vaccines Typical Distributors
Table 123. Infectious Vaccines Typical Customers
Table 1. Global Infectious Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Infectious Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CSL Limited (Australia) Basic Information, Manufacturing Base and Competitors
Table 4. CSL Limited (Australia) Major Business
Table 5. CSL Limited (Australia) Infectious Vaccines Product and Services
Table 6. CSL Limited (Australia) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CSL Limited (Australia) Recent Developments/Updates
Table 8. Bavarian Nordic (Denmark) Basic Information, Manufacturing Base and Competitors
Table 9. Bavarian Nordic (Denmark) Major Business
Table 10. Bavarian Nordic (Denmark) Infectious Vaccines Product and Services
Table 11. Bavarian Nordic (Denmark) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bavarian Nordic (Denmark) Recent Developments/Updates
Table 13. GlaxoSmithKline plc. (U.K.) Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline plc. (U.K.) Major Business
Table 15. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product and Services
Table 16. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline plc. (U.K.) Recent Developments/Updates
Table 18. Emergent Bio Solutions Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 19. Emergent Bio Solutions Inc. (U.S.) Major Business
Table 20. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product and Services
Table 21. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Emergent Bio Solutions Inc. (U.S.) Recent Developments/Updates
Table 23. MedImmune LLC (U.S.) Basic Information, Manufacturing Base and Competitors
Table 24. MedImmune LLC (U.S.) Major Business
Table 25. MedImmune LLC (U.S.) Infectious Vaccines Product and Services
Table 26. MedImmune LLC (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MedImmune LLC (U.S.) Recent Developments/Updates
Table 28. Johnson and Johnson (U.S.) Basic Information, Manufacturing Base and Competitors
Table 29. Johnson and Johnson (U.S.) Major Business
Table 30. Johnson and Johnson (U.S.) Infectious Vaccines Product and Services
Table 31. Johnson and Johnson (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Johnson and Johnson (U.S.) Recent Developments/Updates
Table 33. Novartis AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 34. Novartis AG (Switzerland) Major Business
Table 35. Novartis AG (Switzerland) Infectious Vaccines Product and Services
Table 36. Novartis AG (Switzerland) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novartis AG (Switzerland) Recent Developments/Updates
Table 38. Merck and Company (U.S.) Basic Information, Manufacturing Base and Competitors
Table 39. Merck and Company (U.S.) Major Business
Table 40. Merck and Company (U.S.) Infectious Vaccines Product and Services
Table 41. Merck and Company (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Merck and Company (U.S.) Recent Developments/Updates
Table 43. Sanofi Pasteur (France) Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Pasteur (France) Major Business
Table 45. Sanofi Pasteur (France) Infectious Vaccines Product and Services
Table 46. Sanofi Pasteur (France) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sanofi Pasteur (France) Recent Developments/Updates
Table 48. Pfizer Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 49. Pfizer Inc. (U.S.) Major Business
Table 50. Pfizer Inc. (U.S.) Infectious Vaccines Product and Services
Table 51. Pfizer Inc. (U.S.) Infectious Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Pfizer Inc. (U.S.) Recent Developments/Updates
Table 53. Global Infectious Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Infectious Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Infectious Vaccines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Infectious Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Infectious Vaccines Production Site of Key Manufacturer
Table 58. Infectious Vaccines Market: Company Product Type Footprint
Table 59. Infectious Vaccines Market: Company Product Application Footprint
Table 60. Infectious Vaccines New Market Entrants and Barriers to Market Entry
Table 61. Infectious Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Infectious Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Infectious Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Infectious Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Infectious Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Infectious Vaccines Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Infectious Vaccines Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Infectious Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Infectious Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Infectious Vaccines Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Infectious Vaccines Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Infectious Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Infectious Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Infectious Vaccines Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Infectious Vaccines Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Infectious Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Infectious Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Infectious Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Infectious Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Infectious Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Infectious Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Infectious Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Infectious Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Infectious Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Infectious Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Infectious Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Infectious Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Infectious Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Infectious Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Infectious Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Infectious Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Infectious Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Infectious Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Infectious Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Infectious Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Infectious Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Infectious Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Infectious Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Infectious Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Infectious Vaccines Raw Material
Table 121. Key Manufacturers of Infectious Vaccines Raw Materials
Table 122. Infectious Vaccines Typical Distributors
Table 123. Infectious Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Infectious Vaccines Picture
Figure 2. Global Infectious Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Infectious Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Preventive Vaccine Examples
Figure 5. Therapeutic Vaccine Examples
Figure 6. Global Infectious Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Infectious Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Adults Examples
Figure 9. Pediatrics Examples
Figure 10. Global Infectious Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Infectious Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Infectious Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Infectious Vaccines Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Infectious Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Infectious Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Infectious Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Infectious Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Infectious Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Infectious Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Infectious Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Infectious Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Infectious Vaccines Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Infectious Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Infectious Vaccines Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Infectious Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Infectious Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Infectious Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Infectious Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Infectious Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Infectious Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Infectious Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Infectious Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Infectious Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Infectious Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Infectious Vaccines Market Drivers
Figure 73. Infectious Vaccines Market Restraints
Figure 74. Infectious Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Infectious Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Infectious Vaccines
Figure 78. Infectious Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Infectious Vaccines Picture
Figure 2. Global Infectious Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Infectious Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Preventive Vaccine Examples
Figure 5. Therapeutic Vaccine Examples
Figure 6. Global Infectious Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Infectious Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Adults Examples
Figure 9. Pediatrics Examples
Figure 10. Global Infectious Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Infectious Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Infectious Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Infectious Vaccines Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Infectious Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Infectious Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Infectious Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Infectious Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Infectious Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Infectious Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Infectious Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Infectious Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Infectious Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Infectious Vaccines Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Infectious Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Infectious Vaccines Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Infectious Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Infectious Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Infectious Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Infectious Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Infectious Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Infectious Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Infectious Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Infectious Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Infectious Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Infectious Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Infectious Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Infectious Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Infectious Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Infectious Vaccines Market Drivers
Figure 73. Infectious Vaccines Market Restraints
Figure 74. Infectious Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Infectious Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Infectious Vaccines
Figure 78. Infectious Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
